Quantitative Biomarkers, Genomic Assays, and Demographics Associated with Breast-Conserving Surgery Following Neoadjuvant Therapy in Early-Stage, Hormone Receptor-Positive, HER-Negative Breast Cancer.

Quantitative Biomarkers, Genomic Assays, and Demographics Associated with Breast-Conserving Surgery Following Neoadjuvant Therapy in Early-Stage, Hormone Receptor-Positive, HER-Negative Breast Cancer. Ann Surg Oncol. 2024 Dec; 31(13):8829-8842.

View in: PubMed

subject areas

Adult
Aged
Biomarkers, Tumor
Breast Neoplasms
Female
Follow-Up Studies
Genomics
Humans
Mastectomy, Segmental
Middle Aged
Neoadjuvant Therapy
Neoplasm Recurrence, Local
Neoplasm Staging
Prognosis
Receptor, ErbB-2
Receptors, Estrogen
Receptors, Progesterone

authors with profiles

Dezheng Huo
Sarah Shubeck
Sudha Yarlagadda
Rita Nanda
Frederick Howard